XXXi-Rong Xiao

Xi-Rong Xiao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xi-Rong Xiao has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Li

    State Key Laboratory of Natural Medicines and School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing China

    1 shared publication
  • Chao Gu

    Department of Gastrointestinal Surgery, Suzhou Municipal Hospital, Suzhou, Jiangsu, China

    1 shared publication
  • Duan Ma

    Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China

    1 shared publication
  • Huangfang Xu

    Obstetrics and Gynecology Hospital of Fudan University

    1 shared publication
  • Huanqiang Zhao

    Shenzhen Maternity and Child Healthcare Hospital, Women and Children’s Medical Center, Southern Medical University, China (S.T., H.Z.).

    1 shared publication
  • Lili Gong

    The Shanghai Key Laboratory of Female Reproductive Endocrine‐Related Diseases Obstetrics and Gynecology Hospital, Fudan University Shanghai China

    1 shared publication

Latest Publications

  • Open Access

    Trophoblast Exosomal UCA1 Induces Endothelial Injury through the PFN1‐RhoA/ROCK Pathway in Preeclampsia: A Human‐Specific Adaptive Pathogenic Mechanism

    by Suwen Wu, Yutong Cui, Huanqiang Zhao, Xirong Xiao, Lili Gong, Huangfang Xu, Qiongjie Zhou, Duan Ma, Xiaotian Li

    Preeclampsia is regarded as an evolution‐related disease that has only been observed in humans and our closest relatives, and the important factor contributing to its pathogenesis is endothelial dysregulation secondary to a stressed placenta. Hypoxia‐inducible factor 1 subunit alpha (HIF1α), a highly conserved molecule in virtually all mammals, is regarded as a crucial regulator of the hypoxia adaptation and evolution. Persistent high expression of HIF1α in the placenta is one of the pathogenic mechanisms of preeclampsia. Therefore, human‐specific molecules should link increased HIF1α to preeclampsia. We reported that urothelial cancer associated 1 (UCA1) is a potential mediator because it is a human‐specific long noncoding RNA (lncRNA) that is upregulated in placental tissues and maternal serum from women with preeclampsia and is regulated by HIF1α. The cellular HIF1α‐UCA1 pathway promoted the adaptation of trophoblasts to hypoxia by inducing vascular endothelial growth factor (VEGF) secretion and changes in the levels of key enzymes in glycolysis. On the other hand, circulating exosomal UCA1 secreted from stressed trophoblasts induced vascular endothelial dysfunction, especially excess ROS production, as measured by exosome extraction and a coculture system. At the molecular level, UCA1 physically bound to ubiquitin‐specific peptidase 14 (USP14), which is a deubiquitinating enzyme, and UCA1 functioned as a scaffold to recruit USP14 to profilin 1 (PFN1), an actin‐binding protein contributing to endothelial abnormalities and vascular diseases. This ternary complex inhibited the ubiquitination‐dependent degradation of PFN1 and prolonged its half‐life, further activating the RhoA/Rho‐kinase (ROCK) pathway to induce ROS production in endothelial cells. Taken together, these observations suggest a role for the evolution‐related UCA1 in the HIF1α‐induced adaptive pathogenic mechanism of preeclampsia, promoting the survival of hypoxic trophoblasts and injuring maternal endothelial cells.


  • Open Access

    Coagulopathy complicating intraoperative blood salvage in patients receiving cesarean section: three case reports and a literature review

    by Yang Zhang, Wei-Rong Gu, Xi-Rong Xiao

    Background: Intraoperative cell salvage (ICS) has been used in more than 1100 published obstetrics cases and can reduce the need for allogeneic transfusion effectively. However, ICS could lead to a life-threatening coagulopathy called salvaged blood syndrome (SBS). SBS was reported in several non-obstetric cases but has rarely been reported in obstetric patients. Cases: We reviewed all 841 cell savage cases that occurred in our hospital prior to October 2018. Here, we present 3 cases of coagulopathy in patients who received ICS after cesarean section. The rate of obstetrical SBS in our hospital was 0.46%. Dicussion: Cesarean section was performed without severe hemorrhage, and we performed the surgical hemostatic procedures as usual. Then, several hours after the surgery and after ICS, bleeding occurred, in which hypofibrinogenemia was more severe than expected based on the amount of postpartum hemorrhage. In addition, other marked changes in coagulation function-related parameters, including a decline in the platelet count and obvious prolongation of the PT and aPTT levels, were also observed. More specific and in-depth studies concerning obstetric SBS are needed.


  • Open Access

    The potential of follicle-stimulating hormone peptide-modified triptolide-loaded nanoparticles to induce a mouse model of premature ovarian insufficiency

    by Xiu-Ying Chen, Wu-Lian Chen, Min Ma, Chao Gu, Xi-Rong Xiao, Bin Li

    The use of triptolide (TP) is limited by its poor water solubility and severe toxicity. In this study, we developed an active drug delivery system (TP-loaded nanoparticles) that could help improve the water solubility of TP and decrease its toxicity. Then, we investigated whether TP-loaded nanoparticles could be used to establish a novel premature ovarian insufficiency mouse model. The mice treated with TP-loaded nanoparticles for 35 days displayed normal growth, decreased serum antimullerian hormone, prominent ovarian fibrosis and vacuolar changes, fewer follicles and corpus lutea, increased collapsed oocytes and follicle apoptosis, and sterility. In conclusion, this model appears to show the reproductive characteristics associated with premature ovarian insufficiency in women and will allow us to study the mechanism of the effects of traditional Chinese medicine on gonadal toxicity.